FindTrial
Sign In

effectiveness of autologous platelet rich plasma intra articular injection in knee pain

Study of Efficacy of Intra-articular Injection of Autologous Platelet Rich Plasma in Patients with Grade 2 Osteoarthritis Knee

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042778
Enrollment
30
Registered
2022-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

ICMR PG THESIS GRANT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: KELLGREN LAWRENCE GRADE 2 CHRONIC KNEE PAIN FOR MORE THAN 3 MONTHS DURATION. PATIENTS WITH PRIMARY OSTEOARTHRITIS

Exclusion criteria

Exclusion criteria: ACUTE SIGNIFICANT TRAUMA PATIENTS WITH DIABETES MELLITUS ANY INTRA ARTICULAR INJECTION IN LAST 6 MONTHS PATIENTS WITH BLEEDING DISORDER PATIENTS WITH SECONDARY OSTEOARTHRITIS UNWILLINGNESS TO PARTICIPATE IN STUDY

Design outcomes

Primary

MeasureTime frame
EFFICACY OF PAIN RELIEF ASSESS THE CARTILAGE THICKNESSTimepoint: EFFICACY OF PAIN RELIEF0.1.3 AND 6 MONTHS ASSESS THE CARTILAGE THICKNESS-0 AND 6 MONTHS—

Secondary

MeasureTime frame
ASSESS FUNCTIONAL OUTCOMETimepoint: AT 0,1,3 AND 6 MONTHS—

Countries

India

Contacts

Public ContactDR KALYAANASUNDHARY S

AIIMS BHOPAL

chethan.veera@gmail.com9711306545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026